SGK1 and metabolic dysfunction-associated steatotic liver disease: Elevated expression levels of SGK1 have been observed in a wide spectrum of chronic fibrosis disorders, including MASLD, further supporting its pathological relevance in hepatic fibrosis and metabolic inflammation [24,25,26].